Year archive

CLEO DIAGNOSTICS LTD — 2025 filings

All 38 regulatory filings released by CLEO DIAGNOSTICS LTD (COV) in 2025, sourced directly from the official regulator.

38 Filings

2025 Period

2025 filings (38)

Filing	Released	Lang
Application for quotation of securities - COV 6 pages 18.4KB Regulatory Filings	2025-12-28	English
Application for quotation of securities - COV 6 pages 18.2KB Regulatory Filings	2025-12-28	English
Notification regarding unquoted securities - COV 6 pages 19.6KB Regulatory Filings	2025-12-28	English
Cleansing Notice 1 page 321.6KB Regulatory Filings	2025-12-28	English
Chairman's End of Year Letter to Shareholders 2 pages 488.9KB Regulatory Filings	2025-12-28	English
CLEO Raises $5m to Support U.S. Market Launch 2 pages 544.4KB Regulatory Filings	2025-12-17	English
Proposed issue of securities - COV 6 pages 21.2KB Regulatory Filings	2025-12-17	English
Trading Halt 2 pages 439.6KB Regulatory Filings	2025-12-16	English
Notice under Listing Rule 3.10A 1 page 305.7KB Regulatory Filings	2025-11-27	English
Cleo Strengthens Cash Position with $1.7m R&D Tax Refund 2 pages 497.1KB Regulatory Filings	2025-11-25	English
Results of Annual General Meeting 2 pages 441.0KB Regulatory Filings	2025-11-23	English
CLEO Appoints First Key Opinion Leader to Support US Market 3 pages 544.7KB Regulatory Filings	2025-11-18	English
CLEO Significantly Expands Addressable Market 3 pages 546.8KB Regulatory Filings	2025-11-05	English
Quarterly activities and cashflow report 10 pages 761.6KB Regulatory Filings	2025-10-30	English
CLEO Successfully Completes Stage 1 MDSAP Audit 2 pages 539.0KB Regulatory Filings	2025-10-29	English
Notice of Annual General Meeting/Proxy Form 30 pages 836.3KB Regulatory Filings	2025-09-24	English
Letter to Shareholders 1 page 2.8MB Regulatory Filings	2025-09-24	English
Application for quotation of securities - COV 5 pages 16.5KB Regulatory Filings	2025-09-18	English
Cleo Receives Positive FDA Feedback 2 pages 440.0KB Regulatory Filings	2025-09-14	English
Notice Required Under ASX Listing Rule 3.13.1 1 pag Regulatory Filings	2025-09-04	English
Appendix 4E and 2025 Annual Report 48 pages 2.4MB Regulatory Filings	2025-08-25	English
Appendix 4G and Corporate Governance Statement 33 pages 616.2KB Regulatory Filings	2025-08-25	English
COV Commences Health Economic Study-Support US Market Entry 3 pages 458.7KB Regulatory Filings	2025-08-17	English
Restricted securities to be released from escrow 1 Regulatory Filings	2025-08-14	English
Quarterly activities and cashflow report 10 pages 799.2KB Regulatory Filings	2025-07-20	English
CLEO Strengthens FDA Submission - Access to US Biobank 4 pages 570.9KB Regulatory Filings	2025-06-24	English
Investor Webinar 2 pages 410.8KB Regulatory Filings	2025-06-17	English
Corporate Presentation 22 pages 2.8MB Regulatory Filings	2025-06-11	English
Cleo Advances with Completion of Alpha Testing 3 pages 546.7KB Regulatory Filings	2025-05-11	English
CLEO to Fast Track Development of Ovarian Cancer Test 4 pages 548.6KB Regulatory Filings	2025-04-27	English
CLEO Receives A$845k Research and Development Tax Incentive 2 pages 489.9KB Regulatory Filings	2025-04-23	English
Notification regarding unquoted securities - COV 7 pages 23.8KB Regulatory Filings	2025-04-23	English
Quarterly activities and cashflow report 9 pages 873.3KB Regulatory Filings	2025-04-10	English
CLEO Delivers Commercial Development Milestone 2 pages 530.0KB Regulatory Filings	2025-03-17	English
Appendix 4D and Half Yearly Accounts 22 pages 986.4KB Regulatory Filings	2025-02-26	English
Clarification to ASX Price Query 2 pages 486.1KB Regulatory Filings	2025-02-16	English
Price Query Response 3 pages 935.0KB Regulatory Filings	2025-02-06	English
Quarterly activities and cashflow report 8 pages 932.1KB Regulatory Filings	2025-01-30	English